麗珠集團(000513.SZ)上半年扣非淨利潤10.46億元 同比增長13.73%
格隆匯8月9日丨麗珠集團(000513.SZ)披露2022年半年度報吿,報吿期內,公司實現營業收入63.03億元,同比增長1.08%;實現歸屬於公司股東的淨利潤10.18億元,同比下降4.23%;若剔除非經常性損益項目收益,公司2022年上半年主營業務實現的歸屬於公司股東的淨利潤為10.46億元,同比增長13.73%。
2022年上半年,在國內疫情局部散發及行業監管與准入政策趨嚴的環境下,集團始終堅持“患者生命質量第一”的使命和“做醫藥行業領先者”的願景,專注創新醫藥主業的穩健經營與發展佈局。
在經營管理上,公司不斷髮揮多元化業務結構以及營運管理的優勢,積極應對行業與市場挑戰,進一步提升經營管理與研發效率,加大數字化轉型力度,從產品的臨牀證據、質量、成本、市場份額等各個方面持續強化產品競爭優勢,實現了主營業務收入的穩定與增長,進一步夯實企業可持續發展的基礎與能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.